phenserine has been researched along with tacrine in 4 studies
Studies (phenserine) | Trials (phenserine) | Recent Studies (post-2010) (phenserine) | Studies (tacrine) | Trials (tacrine) | Recent Studies (post-2010) (tacrine) |
---|---|---|---|---|---|
88 | 6 | 39 | 2,141 | 161 | 643 |
Protein | Taxonomy | phenserine (IC50) | tacrine (IC50) |
---|---|---|---|
Chain A, ACETYLCHOLINESTERASE | Tetronarce californica (Pacific electric ray) | 0.0082 | |
Solute carrier family 22 member 2 | Homo sapiens (human) | 0.68 | |
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.1401 | |
Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.1691 | |
Amyloid-beta precursor protein | Homo sapiens (human) | 0.0456 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.7875 | |
Cytochrome P450 2E1 | Homo sapiens (human) | 0.075 | |
Cholinesterase | Homo sapiens (human) | 0.0545 | |
Acyl-CoA desaturase 1 | Rattus norvegicus (Norway rat) | 0.047 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.517 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 6.6 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 6.6 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 6.6 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.1084 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 6.6 | |
Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.0457 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.3 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 6.6 | |
Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.0457 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.078 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.1957 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.0835 | |
Amine oxidase [flavin-containing] A | Bos taurus (cattle) | 0.047 | |
Acetylcholinesterase | Mus musculus (house mouse) | 0.1143 | |
Acetylcholinesterase | Homo sapiens (human) | 0.2576 | |
Acetylcholinesterase | Bos taurus (cattle) | 0.1848 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.517 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.1143 | |
Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.2097 | |
Small conductance calcium-activated potassium channel protein 3 | Rattus norvegicus (Norway rat) | 0.042 | |
Cholinesterase | Equus caballus (horse) | 0.1103 | |
Histamine N-methyltransferase | Rattus norvegicus (Norway rat) | 0.11 | |
Cholinesterase | Mus musculus (house mouse) | 0.0625 | |
Acetylcholine receptor subunit epsilon | Homo sapiens (human) | 0.044 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 6.3 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 6.3 | |
Acyl-CoA:cholesterol acyltransferase | Oryctolagus cuniculus (rabbit) | 0.267 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.1 | |
Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | 0.0995 | |
Carboxylic ester hydrolase | Equus caballus (horse) | 0.0143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X | 1 |
Alley, GM; Brossi, A; Deschamps, JR; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, D; Yu, QS; Zhan, M | 1 |
Chaudhaery, SS; Nath, C; Nazir, A; Roy, KK; Sammi, SR; Saxena, AK; Saxena, G; Shakya, N | 1 |
Brossi, A; De Micheli, E; Deutsch, J; Greig, NH; Holloway, HW; Ingram, DK; Lahiri, DK; Perry, TA; Soncrant, TT; Utsuki, T; Yu, QS | 1 |
4 other study(ies) available for phenserine and tacrine
Article | Year |
---|---|
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship | 2002 |
Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Topics: Acetylcholinesterase; Amyloid beta-Protein Precursor; Benzofurans; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Neurons; Oxepins; Structure-Activity Relationship | 2005 |
Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Avoidance Learning; Caenorhabditis elegans; Carbamates; Catalytic Domain; Cholinesterase Inhibitors; Databases, Factual; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Male; Mice; Models, Molecular; Nootropic Agents; Quantitative Structure-Activity Relationship; Scopolamine | 2010 |
The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.
Topics: Administration, Oral; Alzheimer Disease; Animals; Brain; Cholinesterase Inhibitors; Disease Models, Animal; Half-Life; Infusions, Intravenous; Male; Physostigmine; Rats; Rats, Inbred F344; Tacrine | 2000 |